Rigenerand Competitors and Similar CompaniesClear all
Rigenerand's competitors and similar companies include Immunochina, Fusion Pharmaceuticals, Shoreline Biosciences and TScan Therapeutics.
 Rigenerand Rigenerand is a company offering products for clinical applications of cell-based technologies for regenerative medicine and oncology. |  Immunochina Immunochina is a company that specializes in applying CAR-T technology and gene cell drugs to the treatment of malignant tumors. |  Fusion Pharmaceuticals Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer. |  Shoreline Biosciences Shoreline Biosciences is a biotechnology company that provides proprietary cell therapy technology platforms. |  TScan Therapeutics TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies. | |
Founding Date | Founding Date 2009 | Founding Date 2015 | Founding Date 2014 | Founding Date 2020 | Founding Date 2018 |
Type | Type Private | Type Private | Type Subsidiary | Type Private | Type Public |
Tags | |||||
Locations | Locations Medolla, IT HQ | Locations CN HQ | Locations Hamilton, CA HQ Boston, US | Locations San Diego, US HQ San Diego, US | Locations Waltham, US HQ |
Employees | Employees 5 | Employees 205% increase | Employees 101 | Employees 4716% decrease | Employees 7316% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $2.1m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $10.3m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($94.9m) (FY, 2023) | Net income N/A | Net income ($129.8m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 9.9m (about 10 years ago) | Latest funding round $ 20.6m (over 7 years ago) | Latest funding round N/A | Latest funding round $ 43m (about 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 9.9m | Total funding raised $ 28.1m | Total funding raised $ 170.9m | Total funding raised $ 46m | Total funding raised $ 137.5m |
For sources of this data, please see the company profile
View Company Profiles
Immunochina
HQ
CN
Employees
20↑ 5% increase
Immunochina is a company that specializes in applying CAR-T technology and gene cell drugs to the treatment of malignant tumors.
View companyFusion Pharmaceuticals
HQ
Hamilton, CA
Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer.
View companyShoreline Biosciences
HQ
San Diego, US
Employees
47↓ 16% decrease
Shoreline Biosciences is a biotechnology company that provides proprietary cell therapy technology platforms.
View companyTScan Therapeutics
HQ
Waltham, US
Employees
73↑ 16% increase
TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.
View company